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Abstract
Purpose Infertility is a global problem, but only a minority of couples access assisted reproductive technologies due to 
financial and sociocultural barriers. Complementary and alternative medicine are seen as another option. We aimed to 
determine the impact of complementary and alternative medicine on conception, miscarriage and live birth rates in couples 
not receiving assisted reproductive technology treatments.
Methods The electronic databases EMBASE, PubMed, Web of Science and the Allied and Complementary Medicine Data-
base were systematically searched before March 24th 2020. Reference lists of eligible studies were searched for relevant 
studies. Eligible studies included trials and observational studies that assessed a complementary or alternative medicine 
and conception, miscarriage or live births in men or women not undergoing fertility treatment. Data were extracted by two 
independent reviewers using a pre-designed data collection form. The study protocol was published in the PROSPERO 
database (CRD42018086980).
Results Twenty randomized controlled trials were identified, including 2748 individuals. Most studies did not demonstrate 
any effect of a complementary or alternative medicine on pregnancy, live birth or miscarriage rates. Limited evidence was 
found for a positive effect of herbal therapies taken by women on conception rates. There was substantial diversity in quality 
across the studies.
Conclusion There is limited evidence of the effectiveness of complementary and alternative medicine on improving the 
chances of conception and live births, or increasing miscarriage risk. Owing to the generally sub-optimal quality and het-
erogeneous nature of the evidence, rigorous studies are needed to determine the impact of complementary and alternative 
medicine on fertility.
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Introduction
Infertility is a significant problem which affects 7–16% of 
couples seeking to have children [1, 2]. Assisted repro-
ductive technology (ART) treatment is regularly used to 
help couples experiencing infertility to have a child. How-
ever, inequity in access to ART treatment have been well 
reported, [3–5] and there is evidence for a declining trend 
in the use of ART treatment in the US [6].
Given the disproportionate access to ART treatment 
as well as its potentially high cost, alternatives are often 
sought by couples. Use of complementary and alternative 
medicines (CAM) to treat infertility is common. This may 
be because people perceive CAM to be of lower cost, safer 
or more effective [7]. A 2010 prevalence study from eight 
American community and academic infertility practices 
found that 29% of couples had used a CAM for infertility, 
with 22% trying acupuncture [8].
There is a broad range of CAM that purport to have a 
positive effect on fertility including traditional practices 
such as acupuncture: Chinese medicine remedies; use of 
naturopaths, homeopaths and chiropractors; and cognitive 
and mind–body therapies, such as mindfulness. Although 
the potential impact of these treatments on infertility has 
been assessed within the context of ART treatment [9], 
this has limited interpretation for couples who are not 
receiving ART treatment.
Considering the increasingly wide-ranging use of CAM 
by couples trying to conceive and the inequity in access to 
ART treatment, a comprehensive review on the efficacy of 
CAM treatments in couples not receiving ART treatment is 
essential. Therefore, we present a systematic review of all 
available intervention and observational studies to review 
the impact of a range of CAM on conception, miscarriage 
or live births rates in couples not receiving ART treatment.
Methods
Information sources and search strategy
This review was conducted using a predefined protocol, 
in accordance with PRISMA guidelines (eTable 1) and is 
registered on PROSPERO [10] (CRD42018086980). Four 
electronic databases (EMBASE, PubMed, Web of Science 
and the Allied and Complementary Medicine Database) 
were searched until 24th March 2020 without time and lan-
guage restriction. The computer-based searches combined 
terms related to (1) the interventions, such as alternative or 
complimentary natural therapies (including herbal thera-
pies, traditional Chinese medicine, ayurveda, naturopathy, 
chiropractic, osteopathy, massage, yoga, relaxation ther-
apy, homeopathy, aromatherapy and therapeutic touch) (2) 
pregnancy and related outcomes (e.g., conception, miscar-
riage, birth) and (3) study design (e.g. RCT, longitudinal 
study) in humans (eTable 2). CAM were identified through 
previous CAM publications [11–13] to aid comparison and 
popular fertility websites which provide advice to cou-
ples (https ://www.ferti lityi q.com; https ://www.babyc entre 
.co.uk; https ://www.oviah ealth .com). Two independent 
reviewers (EB, WW, AC, HY, CS, AH) screened the titles 
and abstracts of all studies initially identified according to 
the selection criteria, and any disagreement was resolved 
through consensus or consultation with a third independ-
ent reviewer (CO). Full texts were retrieved from studies 
that satisfied all selection criteria. Reference lists of stud-
ies and reviews identified on the topic were searched to 
identify additional publications.
Selection criteria
Studies were eligible if they: (1) were longitudinal studies, 
randomized controlled trials (RCTs) or non-randomized tri-
als; (2) assessed effects of any CAM (list in eTable 3) in 
men or women seeking to conceive; (3) collected relevant 
endpoints, including conception, miscarriage or live births 
rates; and (4) control and treatments groups only differed on 
the administration of a CAM. Study populations included 
women or men experiencing sub-fertility or infertility due 
to a diagnosed medical condition (e.g. polycystic ovary syn-
drome (PCOS), diminished ovarian reserve) or due to an 
unexplained or unspecified condition. The participants could 
not be receiving in vitro fertilization (IVF) or another ART 
treatment at the time of the trial. No restrictions on length 
of follow-up or language were applied.
Data extraction
The exposures or interventions eligible for inclusion in the 
current review were summarized using the following broad 
groupings: (i) biologically based therapies such as herbal 
extracts and dietary supplements not conventionally recom-
mended for conception or pregnancy (i.e. folic acid would 
not be eligible); (ii) mind–body and behavioral therapies 
(e.g. mindfulness); (iii) body manipulation and energy ther-
apies (e.g. acupuncture); and (iii) traditional (alternative) 
medical systems (e.g. homeopathy). Two authors indepen-
dently extracted data (EB, WW, AC, HY, CS, AH) and a 
consensus was reached in case of any inconsistency with 
involvement of a third author (CO). A predesigned elec-
tronic data abstraction form was used to extract relevant 
information. The form included the following: author, 
year, study design, country, study years, number of par-
ticipants, number lost to follow-up, recruitment process 
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and inclusion/exclusion criteria, CAM, category of CAM 
(Biological/Energy/Body manipulation/Traditional medical 
systems), control group intervention, outcome(s), the num-
ber receiving the CAM, follow-up duration, average age of 
participants, pregnancies in treatment/control groups (N or 
%), miscarriages in treatment/control groups (N or %), live 
births in treatment/control groups (N or %), risk estimate 
for the difference between the therapy and control group, 
adverse events in the CAM group and an open text field 
for additional notes. In case of multiple publications on a 
study, the most up-to-date or comprehensive information 
was extracted.
Statistical analysis
For studies which did not statistically compare the rates of 
the outcome by exposure group the 2-sided chi-squared test 
was conducted using the raw data provided in the manu-
script. Analyses were conducted Stata version 12.0 (Stata 
Corp, College Station, Texas, USA). All P values from 
2-sided tests were considered statistically significant at 
p < 0.05.
Assessing the risk of bias
Two reviewers independently rated the quality of studies 
using the Cochrane Collaboration’s tool (HMY, CO) [14]. 
This tool evaluated seven domains for their risk of bias 
(high, low, or unclear) as follows: random sequence genera-
tion, allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete out-
come data, selective reporting and other biases. We provided 
an overall assessment of the risk of bias in each study as 
follows: if a study had no domains considered at high risk 
and at least four domains deemed low risk (at least one of 
them being random sequence generation or allocation con-
cealment), the study was deemed low risk; if a study had one 
domain at high risk it was deemed to be a high risk study; 
otherwise it was deemed to be of unclear risk. Any disagree-
ments were discussed until a consensus was reached.
To assess the overall quality of evidence, two authors 
applied the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) approach. As indi-
vidual studies were assessed using the Cochrane Collabora-
tion’s tool, assessment of the GRADE approach was only 
applied where two or more studies were identified for an 
exposure–outcome combination. We downgraded the evi-
dence from high quality by one level for each serious study 
limitation that was identified. Study limitations were the 
following: risk of bias, indirectness of evidence, serious 
inconsistency, imprecision of effect estimates or potential 
publication bias. Two or more studies were identified for the 
following exposure and outcome combinations and were, 
therefore, included in the GRADE assessment: antioxidants 
for men and conception; herbal therapies for women and 
conception, acupuncture for women and conception; and 
homeopathy for women and live births.
Meta-analyses were not conducted in part because the 
majority of studies did not assess the same exposure and 
outcome. The few studies that did evaluate the same expo-
sure–outcome combination had important methodological 
heterogeneity, including study quality, population studied 
and study design, which was reflected in statistical hetero-
geneity in a preliminary meta-analysis.
Results
We identified 27,085 publications in our search strategy after 
removal of duplicates. After assessment, 20 original articles 
were identified that evaluated conception, miscarriage or live 
births after the use a CAM (Fig. 1) [15–34]. Table 1, Fig. 2 
and eTable 4 summarize the studies included in the review. 
The results of these studies are presented by endpoint in 
order of the direction of evidence. The quality of evidence 
from these studies is summarized in Table 2. The interven-
tions and results of the studies evaluating conception, live 
births and miscarriages are summarized in eTables 5–7, 
respectively. The included studies evaluated a biological 
CAM (n = 13), energy therapies (n = 4), body manipulations 
(n = 1), traditional CAM (n = 1) or a combination (n = 1).
Conception
Twenty studies investigated conception after treatment with 
a CAM (eTable 5). All studies were RCT. Eleven studies 
were carried out in Europe, three in the USA, two in Aus-
tralia, one each in China, Iran, India and one in China and 
Australia together. Women and men were treated in ten stud-
ies each. Thirteen studies assessed biological based thera-
pies, four studied energy therapies, one each studied body 
manipulation and traditional methods and one assessed a 
combination of body manipulation practices and traditional 
CAM. Of the biological therapies, there were ten antioxi-
dants, one herbal supplement, one dietary supplement and 
one combined herbal and dietary supplement.
Seven studies found evidence for a positive effect of CAM 
treatment on conception and 12 did not show a difference.
Studies reporting no statistically significant effect
Six studies found no statistically significant effect of antioxi-
dants in sexually active men experiencing infertility. Baler-
cia et al. [15] studied the effect of co-enzyme Q10 (200 mg/
day) taken for 6 months with 3 months’ follow-up in a 
placebo-controlled, double-blind RCT of 60 sexually active 
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men with idiopathic infertility. In the treatment group, six 
partners became pregnant compared to three in the control 
group (20.0% vs 13.0% p = 0.301).
In a factorial, placebo-controlled, double-blind RCT, 
Balercia et al. [17] assessed the effect of l-carnitine (3 g/
day), l-acetyl-carnitine (3 g/day), or combined l-carnitine 
(2 g/day) and l-acetyl-carnitine (1 g/day) over a 6-month 
period with 3 months’ follow-up on 60 men with idiopathic 
infertility. Two partners became pregnant in each of the sin-
gle therapy groups, compared to three in the control group 
(13.3% and 13.3% vs 20.0%, p = 0.624). Five partners 
became pregnant in the combined therapy group (33.3% vs 
20.0%, p = 0.409).
Gopinath et al. [16] evaluated the effect of antioxidants 
on 138 men with subfertility in a three-arm, double-blind, 
placebo-controlled RCT. Men received either two tablets of 
antioxidants a day (50 mg co-enzyme Q10, 500 mg l-carni-
tine, 2.5 g lycopene, 12.5 mg zinc), one tablet of antioxidants 
and one placebo tablet, or two placebo tablets for 180 days, 
with up to 6 months of follow-up. There were six concep-
tions for men receiving two tablets of antioxidants, seven 
for men receiving one tablet of antioxidant and two in the 
control group, (13.0% vs 5.6%, p = 0.257) and (16.3% vs 
5.6%, p = 0.135), respectively.
Sigman et al. [18] evaluated the effect of 24 weeks of 
l-carnitine (2 g/day) and l-acetyl-carnitine (1 g/day) on 
Fig. 1  Flow diagram of identification and selection of studies included in the systematic review
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men in a randomized, double-blind placebo-controlled trial 
with no follow-up. Of the 26 men recruited, one man from 
the control group impregnated his partner (11.1% vs 0%, 
p = 0.237).
A three-arm, double-blind RCT by Scott et al. [19] com-
pared the effects of (1) l-selenomethionine (100 μg/day), (2) 
l-selenomethionine with vitamins and (3) a placebo taken 
daily for 3 months on 69 subfertile men. There was 2 weeks’ 
follow-up. Five men in total achieved paternity in the two 
treatment groups compared to none in the placebo group 
(10.9% vs 0.0%, p = 0.145).
Závaczki et al. [20] recruited 26 sexually active men to 
a placebo-controlled RCT of Magnesium-orotate (3 g/day) 
for 90 days with no follow-up. One partner in the treatment 
group became spontaneously pregnant (10.0% vs 0.0%, 
p = 0.305).
Bergmann et al. [21] assessed the effects of 3 months’ 
treatment with a homeopathic preparation of the herbal 
therapy Agnus castus, in a placebo-controlled, double-
blind RCT that recruited 78 women with infrequent or 
absent menstruation. There was 6 months’ follow-up after 
treatment. Two spontaneous pregnancy were found in the 
treatment group and one in the control group (6.7% vs 
3.3%, p = 0.554).
Three studies found no statistically significant effect 
of acupuncture on pregnancy rates. In a double-blind, 
sham-controlled trial, Pastore et al. [22] randomized 96 
women with PCOS to receive either 8 weeks of true or 
sham acupuncture with 3 months of follow-up. Of those 
who were eligible to become pregnant (n = 45), four in the 
acupuncture group and three in the control group became 
pregnant (20.0% vs 12.0%, p = 0.680).
Wu et al. [23] conducted a placebo-controlled, blinded 
factorial trial evaluating the effect of 16 weeks of acu-
puncture and clomiphene on women with PCOS who were 
trying to conceive. They were followed-up for 10 months 
after treatment. Of the 1000 women recruited, there was no 
difference in the number of pregnancies when comparing 
women who received acupuncture and the pharmaceutical 
placebo (n = 250, 12.4%) with women who received sham 
acupuncture and the pharmaceutical placebo (n = 250, 
15.6%) [risk difference: − 2.9 (− 9.6 to 3.9)]. Nor was 
there any difference when comparing all women who 
received acupuncture regardless of whether they received 
clomiphene (n = 500, 20%) with all those who received 
sham acupuncture (n = 500, 21%) [risk difference: − 0.4 
(− 5.8 to 5.1)].
Cochrane et al. [24] conducted a RCT comparing the 
effect of acupuncture and lifestyle changes (diet and exer-
cise advice) with lifestyle modification alone on 56 sub-
fertile women. During the 3 months of intervention and 
12 months’ follow-up, there was no difference in preg-
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receiving lifestyle intervention alone (14.3% vs 10.7%, 
p = 0.992). Twelve months following intervention, ten 
women receiving acupuncture and eight women receiving 
lifestyle intervention alone had become pregnant in total 
(35.7% vs 17.9%, p = 0.131).
The effect of homeopathic therapy on conception was 
assessed in a double-blinded RCT by Wittmann et al. [25]. 
84 women were given 60 drops of Mastodynon or placebo 
to take daily for 3 months with no additional follow-up. 
Nine women each in the treatment and control groups 
became pregnant (21.4% vs 23.1%, p = 0.494).
Finally, Holt et al. [26] conducted a sham-controlled 
double-blinded RCT of eight sessions of reflexology on 
49 women with anovulation over 10 weeks with 2 months 
of follow-up. Four women in the treatment group and two 
women in the control group conceived (19.0% vs 11.1%, 
p = 0.680).
Fig. 2  Summary of the included studies results
Table 2  Quality of evidence 
evaluating complementary and 
alternative medicine use and 
reproductive outcomes
GRADE rating was applied when two or more studies assessed the same exposure and outcome. GRADE 
rating—C: low, the true effect might be markedly different from the estimated effect; D: very low, the true 
effect is probably markedly different from the estimated effect
a Based on ten studies
b Based on three studies;
c Based on four studies;
d Based on two studies
Effect Quality of evidence
Antioxidants for men do not affect rates of  conceptiona Very low (D)
Herbal therapies for women improve rates of  conceptionb Very low (D)
Acupuncture for women does not affect rates of  conceptionc Low (C)
Homeopathy for women has no statistically significant effect on live birth  ratesd Low (C)
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Studies reporting an effect
Arentz et al. [27] assessed the effect of up to 3 months’ use 
of two herbal supplements in 122 overweight women with 
PCOS receiving diet and exercise advice. There was no 
follow-up. The treatment group received a tablet combining 
extracts of Glycyrrhiza glabra, Paeonia lactiflora, Cinnamo-
mum verum and Hypericum perforatum and another con-
taining Tribulus terrestris extract, the latter to be taken dur-
ing follicular phase of the menstrual cycle. Eleven women in 
the treatment group became pregnant and three in the control 
group (32.4% vs 8.3%, p = 0.012).
In a double-blind placebo-controlled trial, Westphal et al. 
[34] investigated the effect of 3 months of FertilityBlend™, 
a nutritional supplement that included herbal extracts, anti-
oxidants, vitamins and minerals, on 30 women who had been 
trying to conceive for 6–36 months. No follow-up period 
was reported. Five women, all of whom had received the 
supplement, became pregnant (33.3% vs 0.0%, p = 0.014).
Four trials found evidence for a positive effect of the 
antioxidants l-carnitine and l-acetyl-carnitine for men with 
subfertility. Cavallini et al. [28] randomized 325 men to one 
of three arms. Treatment group 1 received l-carnitine (2 g/
day) and l-acetyl-carnitine (1 g/day) with a cinnoxicam sup-
pository (30 mg) every 4 days. Treatment group 2 received 
the same doses of l-carnitine and l-acetyl-carnitine and a 
placebo suppository. The control group received oral and 
suppository placebos. Treatment was for 6 months with 
3 months’ further follow-up. Conception rates were signifi-
cantly higher in treatment group 1 than the control group 
(21.8% vs 1.7%, p < 0.001) and treatment group 2 than the 
control group (38.0% vs 1.7%, p < 0.001). Conception rates 
in treatment group 2 were also significantly higher than in 
treatment group 1 (38.0% vs 21.8%, p = 0.012).
In two separate placebo-controlled, double-blind, crosso-
ver trials Lenzi et al. [29, 30] assessed the effect of anti-
oxidants on sexually active men with sub-fertility. In both 
trials, treatment was received for 2 months with 2 months’ 
washout period in between treatments and 2 months’ follow-
up afterwards. The first trial recruited 100 men and evalu-
ated l-carnitine (2 g/day). No pregnancies occurred during 
the control periods, but eight pregnancies occurred during 
treatment (0.0% vs 9.3%, p = 0.004). In a separate trial, 60 
men alternated receiving l-carnitine (2 g/day) with l-acetyl-
carnitine (1 g/day) or placebo. Four pregnancies occurred 
during treatment phases and none during placebo phases 
(13.3% vs 0.0%, p = 0.045).
Busetto et al. [31] investigated the effect of 6 months of 
antioxidants combined with supplements (1000 mg l-car-
nitine, 725 mg fumarate, 500 mg acetyl-l-carnitine, 20 mg 
co-enzyme Q10, 90 mg vitamin C, 10 mg zinc, 100 μg folic 
acid, 1.5 μg B12) on 104 subfertile men in a double-blind 
placebo-controlled RCT. Ten partners in the therapy group 
became pregnant compared to two in the control group in up 
to 6 months’ follow-up (20.4% vs 4.4%, p = 0.021).
Razavi et  al. [32] evaluated the effect of selenium 
(200 μg/day) taken for 2 months on 64 women with PCOS 
in a placebo-controlled RCT with no follow-up. All women 
received the same dose of metformin over the trial period. 
Six women taking selenium and one woman taking the pla-
cebo became pregnant (18.8% vs 3.1%, p = 0.040).
In a RCT by Lim et al. [33] 146 women with PCOS were 
randomized to 3 months of true or sham acupuncture with 
3 months’ follow-up. Five women who had received true 
acupuncture became pregnant whereas none of the women 
in the control group became pregnant (5.1% vs 0.0%, 
p = 0.002).
Miscarriages
Three RCTs from Australia, China and USA evaluated the 
number of miscarriages in men and women when treated 
with a CAM (eTable 6). The studies evaluated a biological 
based therapy (a supplement), a body manipulation practice 
(acupuncture) and a traditional CAM (homeopathy). No 
studies demonstrated that treatment with a CAM affected 
rates of miscarriage.
Studies reporting no statistically significant effect
Arentz et al. [27] evaluated the use of herbal supplements for 
up to 3 months in women with PCOS with no follow-up. Of 
the 11 pregnancies that occurred in the treatment group, four 
ended in miscarriage, while one out of the three pregnancies 
arising in the control group ended in miscarriage (36.4% vs 
33.3%, p = 0.923).
No statistically significant effect of 16 weeks of acupunc-
ture and 10 months of follow-up on miscarriages for women 
with PCOS was reported by Wu et al. [23]. The proportion 
of pregnant women who miscarried was similar in the group 
receiving acupuncture and a placebo (37.3%) and the control 
group (29.1%). Compared to the control group, the risk dif-
ference of miscarriage for women who had acupuncture and 
placebo was 8.2 (− 9.7 to 26.1).
Westphal et al. [34] reported one of the five pregnancies 
that arose in the group receiving 3 months without follow-
up of a herbal and dietary supplement ended in miscarriage 
(20%). No pregnancies occurred in the control group and, 
therefore, no miscarriages.
Live births
Four RCTs investigated treatment with a CAM on the rates 
of live births in women (eTable 7). One study each was from 
Germany, China, Australia and USA. They assessed the 
effects of a biological based therapy (a supplement), a body 
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manipulation practice (acupuncture) and a traditional CAM 
(homeopathy). Only one study found evidence of greater live 
birth rates for women treated with a CAM.
Studies reporting no statistically significant effect
Bergmann et al. [21] conducted a placebo-controlled, dou-
ble-blind RCT of 3 months of homeopathic preparation of 
Agnus castus extract, with 3 months’ follow-up, recruiting 
78 women with infrequent or absent menstruation. There 
were six live births in the treatment group and two in the 
control group (20.0% vs 6.7%, p = 0.129).
Wu et  al. [23] provided no evidence of an effect of 
16 weeks of acupuncture on live birth rates in a placebo-
controlled, blinded, factorial trial of clomiphene and acu-
puncture in women with PCOS that had 10 months’ follow-
up. There was no significant difference in the rate of live 
births between the group receiving active acupuncture and 
a placebo tablet and the control group (16.8%) (13.9%; risk 
difference, − 2.9% [95% CI: − 9.5–3.7%)].
Arentz et al. [27] provided no evidence of an effect of 
up to 3 months of homeopathic preparation (containing 
Glycyrrhiza glabra, Peonia lactiflora, Cinnamonum verum, 
Hypericum perforatum and Tribulus terrestris) on live birth 
rates. There was no follow-up. There were seven live births 
in the treatment group and two in the control group (20.6% 
vs 5.6%, p = 0.060).
Studies reporting an effect
A single study found evidence of a higher rate of live births 
for women receiving a CAM. Westphal et al. [34] rand-
omized women who had tried unsuccessfully to conceive for 
6–36 months to receiving 3 months of a herbal and dietary 
supplement, or a placebo. Although the follow-up duration 
was not reported, all four live births occurred in the treat-
ment group, resulting from five pregnancies that occurred 
during and in the year after the trial.
Study quality
Two out of the 20 included trials demonstrated a high risk 
of bias, as evaluated using the Cochrane Collaboration tool 
(Fig. 3, eTable 8). In both trials the high risk of bias related 
to blinding of participants and personnel. A further 13 trials 
demonstrated an unclear risk of bias in one or more areas, 
while 5 trials had a low risk of bias in all areas of study 
quality.
The GRADE approach was used to determine the qual-
ity of evidence for exposure–outcome combinations where 
two or more studies were identified. The grading based 
on the current review is indicated in Table 2 and Fig. 4. 
Down-grading due to risk of bias, inconsistency and 
imprecision resulted in low to very low evidence.
Discussion
Summary of the findings
This review, based on data from 20 studies, gives an 
important overview of the current knowledge on effects of 
CAM for couples not undergoing ART treatments, related 
to conception, miscarriage and live births. The majority 
of studies demonstrated no statistically significant effect 
of CAM on any of the outcomes, and only eight studies 
reported an advantageous association. Overall, there was 
low to very low evidence of any CAM effecting any repro-
ductive outcomes.
Findings in context of other research into CAM
Although women may avoid conventional and pharmaco-
logical therapy during pregnancy due to potential adverse 
effects [35, 36], CAM are often perceived as natural and 
safe [37]. However, research is lacking on the efficacy and 
safety of CAM among pregnant and postpartum women 
even for commonly used herbal therapies [38]. The most 
pressing issue from couples’ perspectives is whether the 
use of a CAM will affect their risk of pregnancy loss or 
having a live born child. Only 3 out of the 20 identified 
studies reported the number of miscarriages, and only 4 
studies evaluated the probability of having a live born 
child. Furthermore, no studies evaluated time to preg-
nancy. This marked lack of research in this area will only 
compound the limited advice and guidance that caregivers 
can provide to couples who wish to have a child.
The focus on this review, on CAM use outside of ART 
treatment, does not negate potential benefits of CAM use 
for couples seeking to conceive with ART treatment or for 
women during pregnancy. A previous systematic review of 
the evidence from trials for CAM during infertility treatment 
found preliminary evidence of the effectiveness of some 
CAM interventions [9]. Three or more clinical trials reported 
results that were consistent with a positive effect of the use 
of acupuncture, selenium supplementation, weight loss and 
psychotherapy during infertility treatment. Acupuncture has 
also been reported to be beneficial as an adjunct to standard 
analgesia during oocyte retrieval for IVF [9] and to have a 
beneficial effect on back pain during pregnancy [23].
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Strengths and limitations of the current evidence 
and directions for future research
To the authors’ knowledge this is the first review of CAM 
use in couples not undergoing ART treatment. Strengths 
include the wide range of CAM included in the search 
terms and multiple databases used in the search, although 
this limited detailed evaluation of each CAM. Synthesis of 
the existing knowledge on this topic was challenging due 
to inconsistent findings between some studies evaluating 
similar CAM (e.g. Balercia et al. [17] and Cavallini et al. 
[28]), which may partly reflect differences in the dose, for-
mulation or route of administration of CAM used in studies 
theoretically evaluating the same exposure. Publication bias 
may also have impacted the review, although the majority 
of the studies have small sample sizes and did not report an 
effect on reproductive outcomes. Furthermore, the majority 
of included studies are from European populations, which 
might limit the generalizability of the findings to other popu-
lations, and the quality of studies was generally poor. Other 
important factors such as differences in underlying fertility 
risk factors in study populations and variability in adjust-
ment levels prevent quantitative synthesis of the studies.
The importance of age in the included studies cannot be 
overstated. A major determinant of fertility in women, age 
impacts ovarian reserves and, therefore, the quantity and 
quality of oocytes available for fertilization. The ability to 
become pregnant at the age of 34–35 is 14% lower than at 
the ages of 30–31, which decreases to 50% by the age of 
40 [39]. Therefore, the variation in the mean age of female 
participants in the included studies, from 26 to 34, will have 
a large effect on the probability of conception and introduced 
between-study heterogeneity to this review.
Our review should stimulate further research in this area. 
The aforementioned few studies assessing miscarriage, 
live birth rates and time to pregnancy is a major gap in the 
Fig. 3  Quality of studies in the review as assessed by the Cochrane Collaboration’s tool
833Archives of Gynecology and Obstetrics (2021) 303:821–835 
1 3
literature. The latter is particularly pertinent; many studies 
assessed conceptions but neglected to conduct any statisti-
cal analyses assessing time to pregnancy. Furthermore, the 
majority of identified studies assessed biological CAM. In 
general, the small number of individuals included in most of 
the studies (number of participants recruited: mean = 137, 
median = 74) strongly suggests the studies may lack power to 
detect any significant effect of a CAM and call into question 
whether significant results reflect chance findings.
To comprehensively investigate the role of CAM, it 
may be necessary to conduct large population-based stud-
ies rather than RCTs. Previous surveys indicate that large 
numbers of couples use CAM when trying to get pregnant 
[8] or during pregnancy [40]. Given the small numbers of 
participants in the trials included in this review (18 studies 
had < 200 participants), and the relatively short follow-up 
durations (range: 0–12 months), a cohort study with large 
numbers of participants followed for a sufficient amount of 
time (> 5 years) may be more feasible. This would also have 
the advantage of including women and men with a wide 
range of ages and, therefore, having the potential to evaluate 
the effects of a CAM at different ages. A good example of 
this is the cohort study of over 25,000 individuals evaluating 
whether use of acupuncture after stroke reduced the risk of 
pneumonia [41].
Conclusion
The current review presents a cutting-edge summary of 
CAM and pregnancy outcomes. However, the findings of 
this article should be treated cautiously. The quality of many 
studies included in this review was low, although findings 
were based on RCTs. Use of CAM should be based on evi-
dence and attention should be paid to negative effects, such 
as a potential increased risk of miscarriage. Also, it is rec-
ommended that medical professionals discuss with patients 
who approach them with fertility problems about whether 
they are using any CAM. Although no negative effects on 
conception were reported, side effects were prevalent. These 
include diarrhea [20], euphoria [28] and headaches [24].
Overall, the evidence on CAM and pregnancy outcomes 
for individuals not using ART treatment is not robust due to 
low study quality and small sample sizes. There is limited 
Fig. 4  Clinical implications 
of findings on complementary 
and alternative medicines and 
reproductive outcomes. Quality 
of evidence assessed using 
Grading of Recommendations 
Assessment, Development and 
Evaluation (GRADE): C: low 
quality of evidence (our confi-
dence in the effect estimate is 
limited: The true effect may be 
substantially different from the 
estimate of the effect). D: very 
low quality of evidence (out 
confidence in the effect esti-
mates is severely limited. The 
true effect is probably markedly 
different from the estimated 
effect)
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support for the role of different CAM, such as herbal thera-
pies in enhancing the chances of conception and subsequent 
live births.
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